BRIEF

on Medicus Pharma Ltd (NASDAQ:MDCX)

Medicus Pharma to Participate in Dubai Family Office Summit

Medicus Pharma Ltd., a biotech/life sciences company, will present at the Family Office Summit in Dubai. The event, themed "Unlocking the $1 Trillion Wealth Transfer in Dubai," will feature Dr. Raza Bokhari, Executive Chairman & CEO of Medicus, discussing biotech innovations and AI's role in drug development. The summit gathers global leaders to discuss wealth transfer dynamics in Dubai.

Medicus is progressing with its Phase 2 clinical study for SKNJCT-003, which targets basal cell carcinoma using dissolvable microneedle arrays. The study received positive interim results and FDA feedback. The company has also acquired UK-based Antev, developing Teverelix for prostate cancer patients, aiming to improve outcomes through a sustained-release formulation.

R. E.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Medicus Pharma Ltd news